The FDA is requesting that manufacturers of bacitracin for injection voluntarily withdraw their product.
Data tracked by wearable fitness sensors may help with real-time surveillance of seasonal respiratory infections, such as influenza.
The 2019 Novel Coronavirus outbreak in Wuhan City, China has caused concern as 2 cases have been recently reported in the United States.
Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.
Fewer tracheobronchial branches may be a genetically-related risk factor.